Oramed製藥 ORMP 深 滬
已收盤 02-06 16:00:00 美东时间
3.41
+0.170
+5.25%
華盛通- 最 高3.41
- 今 開3.28
- 成交量 16.71万股
- 最 低 3.22
- 昨 收 3.24
- 總市值 1.36亿
- 52周最高 3.65
- 市盈率 靜 25.04
- 換手率 0.42%
- 52周最低 1.57
- 委 比 -50.50%
- 總股本 3980.25万
- 歷史最高 31.48
- 量 比 1.02
- 振 幅 5.86%
- 歷史最低 -0.05
- 每 手 1
- 風險率 0.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多UPDATE: Lifeward To Acquire Oramed's POD Technology And Secure Up To $47M Strategic Investment As Oramed Takes Up To 49.99% Stake
Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and Positions Oramed as a Significant Shareholder
01-13 21:18
Oramed and Lifeward Announce Strategic Transaction
Transaction Will Transfer Oramed's Oral Drug Delivery Platform (POD™ Technology) to Lifeward and Positions Oramed as a Significant Shareholder Oramed will transfer POD™ platform to Lifeward ...
01-13 20:58
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
Lifeward Ltd has secured up to $47 million in strategic investment from Oramed Pharmaceuticals and another investor to drive profitability and diversify its portfolio into biotech. Lifeward acquired Oramed's Protein Oral Delivery (POD™) technology, targeting the $600+ billion injectable drugs market, including the potential first oral insulin medicine, ORMD-0801. The transaction allows Lifeward to focus on existing MedTech products like ReWalk an...
01-13 13:00
Oramed Pharm Announces Dividend After Scilex Payment Gain
Oramed Pharm ( ($ORMP) ) has provided an update. On January 7, 2026, Oramed Pha...
01-07 22:17
Oramed receives $18 million payment from Scilex, approves $0.25 per share dividend
Oramed Pharmaceuticals (ORMP) on Wednesday said that it has received an $18 million payment from Scilex Holdings, completing Scilex’s obligations under an option agreement. The company said the paymen...
01-07 22:12
Oramed Pharm Announces Long-Tenured Director’s Upcoming Resignation
Oramed Pharm ( ($ORMP) ) just unveiled an update. On December 31, 2025, Oramed ...
01-01 06:00
Oramed Pharm Declares Dividend Amidst Takeover Defense
Oramed Pharm ( ($ORMP) ) has provided an announcement. On November 16, 2025, Or...
2025-11-17 22:19
Oramed Pharmaceuticals GAAP EPS of $1.26
Oramed Pharmaceuticals press release (ORMP): nine-month period 2025 GAAP EPS of $1.26. Robust balance sheet growth: Total assets increased 42% from $155.3 million to $220.5 million year-over-year. Ope...
2025-11-17 22:14
Reported November 13, 2025: Oramed Pharmaceuticals Q3 EPS $1.26 Beats $(0.08) Estimate, Sales $2.000M
Oramed Pharmaceuticals (NASDAQ:ORMP) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $(0.08) by 1675 percent. This is a 672.73 percent increase over losses of $(0.22) per share
2025-11-17 21:58
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
NEW YORK, Nov. 17, 2025 /PRNewswire/ -- The Board of Directors of Oramed Pharmaceuticals Inc. (the "Company") announced today that it has unanimously adopted a Rights Agreement, dated Novemb...
2025-11-17 21:50
